XML 46 R32.htm IDEA: XBRL DOCUMENT v3.19.1
Equity (Tables)
3 Months Ended
Mar. 31, 2019
Equity  
Schedule of stock based compensation expense

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 31, 

 

(in millions)

    

2019

    

2018

 

Stock options:

 

 

 

 

 

 

 

Pre-tax compensation expense

 

$

 1

 

$

 1

 

Income tax benefit

 

 

 —

 

 

 —

 

Stock option expense, net of income taxes

 

 

 1

 

 

 1

 

 

 

 

 

 

 

 

 

Restricted stock units ("RSUs"):

 

 

 

 

 

 

 

Pre-tax compensation expense

 

 

 2

 

 

 3

 

Income tax benefit

 

 

 —

 

 

(1)

 

RSUs, net of income taxes

 

 

 2

 

 

 2

 

 

 

 

 

 

 

 

 

Performance shares and other share-based awards:

 

 

 

 

 

 

 

Pre-tax compensation expense

 

 

 1

 

 

 1

 

Income tax benefit

 

 

 —

 

 

 —

 

Performance shares and other share-based compensation expense, net of income taxes

 

 

 1

 

 

 1

 

 

 

 

 

 

 

 

 

Total share-based compensation:

 

 

 

 

 

 

 

Pre-tax compensation expense

 

 

 4

 

 

 5

 

Income tax benefit

 

 

 —

 

 

(1)

 

Total share-based compensation expense, net of income taxes

 

$

 4

 

$

 4

 

 

Schedule of valuation assumptions for stock options

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 

 

 

    

2019

 

2018

 

Expected life (in years)

 

5.5

 

 

5.5

 

 

Risk-free interest rate

 

2.5

%

 

2.5

%

 

Expected volatility

 

19.7

%

 

19.8

%

 

Expected dividend yield

 

2.7

%

 

1.8

%

 

 

Schedule of stock option transactions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

Number of Options (in thousands)

    

Weighted Average Exercise Price per Share

    

Average Remaining Contractual Term (Years)

    

Aggregate Intrinsic Value (in millions)

 

Outstanding as of December 31, 2018

 

2,079

 

$

80.25

 

5.51

 

$

42

 

Granted

 

247

 

 

91.85

 

 

 

 

 

 

Exercised

 

(60)

 

 

32.99

 

 

 

 

 

 

Cancelled

 

(22)

 

 

121.87

 

 

 

 

 

 

Outstanding as of March 31, 2019

 

2,244

 

$

82.38

 

5.83

 

$

43

 

Exercisable as of March 31, 2019

 

1,783

 

$

75.57

 

5.16

 

$

42

 

 

Schedule of additional information pertaining to stock option activity

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 31, 

 

(dollars in millions, except per share)

    

2019

    

2018

  

Weighted average grant date fair value of stock options granted (per share)

 

$

14.02

 

$

24.01

 

Total intrinsic value of stock options exercised

 

$

 4

 

$

 8

 

 

Schedule of restricted unit activity

 

 

 

 

 

 

 

(RSUs in thousands)

    

Number of RSUs

    

Weighted Average Fair Value per Share

 

Non-vested as of December 31, 2018

 

341

 

$

115.06

 

Granted

 

148

 

 

91.94

 

Vested

 

(123)

 

 

100.20

 

Cancelled

 

(15)

 

 

121.62

 

Non-vested as of March 31, 2019

 

351

 

$

110.25

 

 

Summary of net changes in accumulated other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(in millions)

    

Cumulative Translation Adjustment

    

Deferred (Loss) Gain on Hedging Activities

    

Pension and Postretirement Adjustment

    

Unrealized (Loss) Gain on Investment

    

Accumulated Other Comprehensive Loss

   

Balance, December 31, 2018

 

$

(1,080)

 

$

(5)

 

$

(69)

 

$

 —

 

$

(1,154)

 

Other comprehensive income (loss) before reclassification adjustments

 

 

 1

 

 

(12)

 

 

 —

 

 

 —

 

 

(11)

 

Amount reclassified from accumulated OCI

 

 

 —

 

 

 2

 

 

 —

 

 

 —

 

 

 2

 

Tax benefit

 

 

 —

 

 

 3

 

 

 —

 

 

 —

 

 

 3

 

Net other comprehensive income (loss)

 

 

 1

 

 

(7)

 

 

 —

 

 

 —

 

 

(6)

 

Balance, March 31, 2019

 

$

(1,079)

 

$

(12)

 

$

(69)

 

$

 —

 

$

(1,160)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(in millions)

    

Cumulative Translation Adjustment

    

Deferred (Loss) Gain on Hedging Activities

    

Pension and Postretirement Adjustment

    

Unrealized (Loss) Gain on Investment

    

Accumulated Other Comprehensive Loss

   

Balance, December 31, 2017

 

$

(951)

 

$

(13)

 

$

(51)

 

$

 2

 

$

(1,013)

 

Other comprehensive income (loss) before reclassification adjustments

 

 

21

 

 

22

 

 

(1)

 

 

 1

 

 

43

 

Amount reclassified from accumulated OCI

 

 

 —

 

 

 4

 

 

 —

 

 

 —

 

 

 4

 

Tax provision

 

 

 —

 

 

(6)

 

 

 —

 

 

 —

 

 

(6)

 

Net other comprehensive income (loss)

 

 

21

 

 

20

 

 

(1)

 

 

 1

 

 

41

 

Balance, March 31, 2018

 

$

(930)

 

$

 7

 

$

(52)

 

$

 3

 

$

(972)

 

 

Schedule of stockholders equity and redeemable equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Equity

 

Share-based

 

 

 

 

 

 

Additional

 

 

 

 

Accumulated Other

 

 

 

 

Non-

 

Payments

 

 

 

Common

 

Paid-In

 

Treasury

 

Comprehensive

 

Retained

 

Controlling

 

Subject to

 

(in millions)

    

Stock

    

Capital

    

Stock

    

Loss

    

Earnings

    

Interests

    

Redemption

 

Balance, December 31, 2018

 

$

 1

 

$

1,096

 

$

(1,091)

 

$

(1,154)

 

$

3,536

 

$

20

 

$

37

 

Net income attributable to Ingredion

 

 

 

 

 

 

 

 

 

 

 

 

 

 

100

 

 

 

 

 

 

 

Net income attributable to non-controlling interests

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 2

 

 

 

 

Dividends declared, common stock ($0.625/share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(42)

 

 

 

 

 

 

 

Repurchases of common stock

 

 

 

 

 

32

 

 

31

 

 

 

 

 

 

 

 

 

 

 

 

 

Share-based compensation, net of issuance

 

 

 

 

 

 9

 

 

10

 

 

 

 

 

 

 

 

 

 

 

(16)

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

(6)

 

 

 

 

 

 

 

 

 

 

Balance, March 31, 2019

 

$

 1

 

$

1,137

 

$

(1,050)

 

$

(1,160)

 

$

3,594

 

$

22

 

$

21

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Equity

 

Share-based

 

 

 

 

 

 

Additional

 

 

 

 

Accumulated Other

 

 

 

 

Non-

 

Payments

 

 

 

Common

 

Paid-In

 

Treasury

 

Comprehensive

 

Retained

 

Controlling

 

Subject to

 

(in millions)

    

Stock

    

Capital

    

Stock

    

Loss

    

Earnings

    

Interests

    

Redemption

 

Balance, December 31, 2017

 

$

 1

 

$

1,138

 

$

(494)

 

$

(1,013)

 

$

3,259

 

$

26

 

$

36

 

Net income attributable to Ingredion

 

 

 

 

 

 

 

 

 

 

 

 

 

 

140

 

 

 

 

 

 

 

Net income attributable to non-controlling interests

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 3

 

 

 

 

Dividends declared, common stock ($0.60/share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(44)

 

 

 

 

 

 

 

Dividends declared, non-controlling interests

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3)

 

 

 

 

Share-based compensation, net of issuance

 

 

 

 

 

(6)

 

 

18

 

 

 

 

 

 

 

 

 

 

 

(9)

 

Other comprehensive income (loss)

 

 

 

 

 

 

 

 

 

 

 

41

 

 

 

 

 

(2)

 

 

 

 

Balance, March 31, 2018

 

$

 1

 

$

1,132

 

$

(476)

 

$

(972)

 

$

3,355

 

$

24

 

$

27

 

 

Schedule of basic and diluted earnings per common share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

Three Months Ended March 31, 2019

    

Three Months Ended March 31, 2018

    

(in millions, except per share amounts)

   

Net Income Available to Ingredion

    

Weighted Average Shares

    

Per Share Amount

    

Net Income Available to Ingredion

    

Weighted Average Shares

    

Per Share Amount

    

Basic EPS

 

$

100

 

66.8

 

$

1.50

 

$

140

 

72.3

 

$

1.94

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Effect of Dilutive Securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards

 

 

 

 

0.6

 

 

 

 

 

 

 

1.3

 

 

 

 

Diluted EPS

 

$

100

 

67.4

 

$

1.48

 

$

140

 

73.6

 

$

1.90